The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). (Q33967469)

30 July 2017

1 reference

title

The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). (English)

1 reference

30 July 2017

Uriel Halbreich

1

1 reference

30 July 2017

Jeff Borenstein

series ordinal

2

1 reference

30 July 2017

Terry Pearlstein

series ordinal

3

1 reference

30 July 2017

Linda S Kahn

series ordinal

4

1 reference

30 July 2017

1 August 2003

1 reference

30 July 2017

Psychoneuroendocrinology

1 reference

30 July 2017

28 Suppl 3

1 reference

30 July 2017

1-23

1 reference

The epidemiology of perimenstrual psychological symptoms.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Depressive symptoms as a predictor of 6-month outcomes and services utilization in elderly medical inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The impact of allergies and allergy treatment on worker productivity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Severe perimenstrual symptoms: prevalence and effects on absenteeism and health care seeking in a non-clinical sample

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Premenstrual syndrome in employed Chinese women in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Relationship between premenstrual tension syndrome and anxiety in Chinese adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Effects of an educational programme on adolescents with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Premenstrual dysphoric disorder: is there an economic burden of illness?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Premenstrual symptoms. Prevalence and severity in an adolescent sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Biological, social, and behavioral factors associated with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The efficacy of short-term treatment for improving quality of life: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Influence of premenstrual syndrome on family, social life, and work performance

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Premenstrual changes: patterns and correlates of daily ratings

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The economic burden of migraine to society

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Premenstrual symptoms and dysmenorrhea in relation to emotional distress factors in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

A design for studying the DSM-IV research criteria of premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The multinational impact of migraine symptoms on healthcare utilisation and work loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Awareness, diagnosis, and treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Impact of illness and its treatment on workplace costs: regulatory and measurement issues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The economic burden of anxiety disorders in the 1990s.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Premenstrual syndromes: closing the 20th century chapters

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Cross Cultural Study of Premenstrual Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The epidemiology and social impact of premenstrual symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Health care utilization by migraine patients: a 1998 Medicaid population study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Effect of primary care treatment of depression on service use by patients with high medical expenditures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Depression and outpatient medical utilization: a naturalistic 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Premenstrual syndrome: diagnosis and treatment experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Perception of family and work environments in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Burden of migraine: societal costs and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Distress associated with menstruation among Israeli women.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The premenstrual syndrome. Effects of "medical ovariectomy"

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Late luteal phase dysphoric disorder in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Prevalence and correlates of perimenstrual symptoms: a study of Israeli teenage girls

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Depression and work productivity: the comparative costs of treatment versus nontreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Cost-effectiveness of systematic depression treatment for high utilizers of general medical care

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Current issues in the economics of depression management

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Menstrual cycle symptom reporting in three British ethnic groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Lowered estimates--but of what?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Postnatal depression: use of health services and satisfaction with health-care providers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Assessment of social adjustment by patient self-report

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

1 reference

7 January 2021

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Prevalene of perimenstrual symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

Perimenstrual symptoms among Chinese women in an urban area of China

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900098-2

7 January 2021

10.1016/S0306-4530(03)00098-2

Identifiers

DOI

0 references

1 reference